These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 36786981)

  • 1. Relationship of Covid-19 Severity with SARS-CoV-2 NS8 Protein Mutations Depending on Virus Strain.
    Shkurnikov MY; Averinskaya DA; Komarov AG; Karbyshev IA; Speshilov GI; Shtinova IA; Doroshenko DA; Vechorko VI
    Dokl Biochem Biophys; 2022 Dec; 507(1):242-246. PubMed ID: 36786981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome characterization based on the Spike-614 and NS8-84 loci of SARS-CoV-2 reveals two major possible onsets of the COVID-19 pandemic.
    Hu X; Mu Y; Deng R; Yi G; Yao L; Zhang J
    PLoS One; 2023; 18(6):e0279221. PubMed ID: 37319292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of ORF8 sequence and immunoinformatics features during alpha, delta, and wild type peaks of the SARS-CoV-2 pandemic in Iran.
    Tabibzadeh A; Karbalaie Niya MH; Keyvani H; Karampoor S; Yousefi P; Razizadeh MH; Mousavizadeh L; Esghaei M
    Malawi Med J; 2023 Jun; 35(2):101-105. PubMed ID: 38264170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective ORF8 dimerization in SARS-CoV-2 delta variant leads to a better adaptive immune response due to abrogation of ORF8-MHC1 interaction.
    Chaudhari AM; Singh I; Joshi M; Patel A; Joshi C
    Mol Divers; 2023 Feb; 27(1):45-57. PubMed ID: 35243596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominance of Three Sublineages of the SARS-CoV-2 Delta Variant in Mexico.
    Taboada B; Zárate S; García-López R; Muñoz-Medina JE; Sanchez-Flores A; Herrera-Estrella A; Boukadida C; Gómez-Gil B; Selem Mojica N; Rosales-Rivera M; Salas-Lais AG; Gutiérrez-Ríos RM; Loza A; Rivera-Gutierrez X; Vazquez-Perez JA; Matías-Florentino M; Pérez-García M; Ávila-Ríos S; Hurtado JM; Herrera-Nájera CI; Núñez-Contreras JJ; Sarquiz-Martínez B; García-Arias VE; Santiago-Mauricio MG; Martínez-Miguel B; Enciso-Ibarra J; Cháidez-Quiróz C; Iša P; Wong-Chew RM; Jiménez-Corona ME; López S; Arias CF
    Viruses; 2022 May; 14(6):. PubMed ID: 35746637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dynamic change of SARS-CoV-2 variants in Sierra Leone.
    Lin L; Zhang J; Rogers J; Campbell A; Zhao J; Harding D; Sahr F; Liu Y; Wurie I
    Infect Genet Evol; 2022 Mar; 98():105208. PubMed ID: 34999288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses.
    Kannan SR; Spratt AN; Cohen AR; Naqvi SH; Chand HS; Quinn TP; Lorson CL; Byrareddy SN; Singh K
    J Autoimmun; 2021 Nov; 124():102715. PubMed ID: 34399188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early introduction, dispersal and evolution of Delta SARS-CoV-2 in Southern Brazil, late predominance of AY.99.2 and AY.101 related lineages.
    Gularte JS; da Silva MS; Mosena ACS; Demoliner M; Hansen AW; Filippi M; Pereira VMAG; Heldt FH; Weber MN; de Almeida PR; Hoffmann AT; Valim ARM; Possuelo LG; Fleck JD; Spilki FR
    Virus Res; 2022 Apr; 311():198702. PubMed ID: 35104582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting SARS-CoV-2 variant distribution in military hospitals in Jordan.
    Khasawneh RH; Almharat SS; Al-Smadi RA; Abasi L; Al-Amr M; Alhuniti AS; Almuhasen AM; Dojan MA; Alshdifat OI; Faheem A
    Diagn Microbiol Infect Dis; 2022 Nov; 104(3):115771. PubMed ID: 36081317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the peptide binding affinity changes in population-specific HLA repertoires to the SARS-CoV-2 variants Delta and Omicron.
    Chen LC; Nersisyan S; Wu CJ; Chang CM; Tonevitsky A; Guo CL; Chang WC
    J Autoimmun; 2022 Dec; 133():102952. PubMed ID: 36427410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomics of postvaccination SARS-CoV-2 infections during the Delta dominated second wave of COVID-19 pandemic, from Mumbai Metropolitan Region (MMR), India.
    Nilgiriwala K; Kadam P; Patel G; Shaikh A; Mestry T; Vaswani S; Sakthivel S; Poojary A; Gandhi B; Rohra S; Udwadia Z; Oswal V; Shah D; Gomare M; Sriraman K; Mistry N
    J Med Virol; 2022 Sep; 94(9):4206-4215. PubMed ID: 35578378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters.
    Mohandas S; Yadav PD; Shete A; Nyayanit D; Jain R; Sapkal G; Mote C
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bias of Asparagine to Lysine mutations in SARS-CoV-2 outside the receptor binding domain affects protein flexibility.
    Boer JC; Pan Q; Holien JK; Nguyen TB; Ascher DB; Plebanski M
    Front Immunol; 2022; 13():954435. PubMed ID: 36569921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2.
    Hassan SS; Kodakandla V; Redwan EM; Lundstrom K; Pal Choudhury P; Abd El-Aziz TM; Takayama K; Kandimalla R; Lal A; Serrano-Aroca Á; Azad GK; Aljabali AAA; Palù G; Chauhan G; Adadi P; Tambuwala M; Brufsky AM; Baetas-da-Cruz W; Barh D; Azevedo V; Bazan NG; Andrade BS; Santana Silva RJ; Uversky VN
    PeerJ; 2022; 10():e13136. PubMed ID: 35341060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phylogeography and genomic analysis of SARS-CoV-2 delta variant in Morocco.
    El Mazouri S; Bendani H; Boumajdi N; Aanniz T; Kandoussi I; Amzazi S; Belyamani L; Ibrahimi A; Ouadghiri M
    J Infect Dev Ctries; 2022 Aug; 16(8):1258-1268. PubMed ID: 36099368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Isaeva OI; Ketelaars SLC; Kvistborg P
    Front Immunol; 2022; 13():891524. PubMed ID: 35572563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
    Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
    mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in spike protein T cell epitopes of SARS-COV-2 variants: Plausible influence on vaccine efficacy.
    Sankaranarayanan S; Mohkhedkar M; Janakiraman V
    Biochim Biophys Acta Mol Basis Dis; 2022 Sep; 1868(9):166432. PubMed ID: 35568352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Epidemiology of the Norwegian SARS-CoV-2 Delta Lineage AY.63.
    Moen LV; Vollan HS; Bråte J; Hungnes O; Bragstad K
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.